PCM Encore LLC Buys New Position in CVS Health Corporation $CVS

PCM Encore LLC purchased a new position in CVS Health Corporation (NYSE:CVS) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 5,997 shares of the pharmacy operator’s stock, valued at approximately $620,000.

Other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd lifted its holdings in shares of CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares during the last quarter. Swiss RE Ltd. bought a new position in CVS Health in the fourth quarter valued at $26,000. Sankala Group LLC purchased a new stake in CVS Health during the fourth quarter valued at about $28,000. Global Trust Asset Management LLC lifted its stake in CVS Health by 344.8% during the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 300 shares during the last quarter. Finally, Mcguire Capital Advisors Inc. bought a new stake in CVS Health during the fourth quarter worth about $28,000. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several recent research reports. Robert W. Baird set a $107.00 price objective on CVS Health in a research report on Thursday, August 6th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. upped their target price on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Cantor Fitzgerald lifted their price target on shares of CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. Finally, Wells Fargo & Company boosted their price objective on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Stock Performance

Shares of NYSE:CVS opened at $93.83 on Friday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The company has a 50-day moving average price of $102.19 and a 200-day moving average price of $88.83. The company has a market cap of $120.01 billion, a price-to-earnings ratio of 24.82, a price-to-earnings-growth ratio of 0.89 and a beta of 0.61. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same period last year, the firm earned $1.81 earnings per share. CVS Health’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health’s payout ratio is 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.